AKYA
Market cap | $67.94 Million |
---|---|
Enterprise Value | $148.11 Million |
Dividend Yield | $0 (0%) |
Earnings per Share | $-1.12 |
Beta | 1.35 |
Outstanding Shares | 49,664,515 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -1.42 |
---|---|
PEG | 4.26 |
Price to Sales | 1.36 |
Price to Book Ratio | -1.36 |
Enterprise Value to Revenue | 1.85 |
Enterprise Value to EBIT | -3.84 |
Enterprise Value to Net Income | -4 |
Total Debt to Enterprise | 0.68 |
Debt to Equity | -17.07 |
No data
No data
As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow ...